期刊文献+

同种异基因皮肤移植对小鼠抗肿瘤效应的影响 被引量:1

Influence of allogeneic skin transplantation on the anti-tumor effects in mice
在线阅读 下载PDF
导出
摘要 目的:研究同种异基因皮肤移植的排斥反应对小鼠抗肿瘤能力的影响。方法:将BALB/c鼠(H-2~d基因型)分成同种皮肤移植组(C57BL/6鼠为供者,H-2b基因型)、同系皮肤移植组(其他BALB/c鼠为供者)和未移植组,分别皮下接种C57BL/6鼠来源的黑色素瘤细胞(B16,H-2b基因型)或者BALB/c鼠来源的骨髓瘤细胞(SP2/0,H-2~d基因型),观察移植排斥和肿瘤生长情况,检测脾细胞群中的CD3^+、CD8^+T细胞和H-2K^b同种反应性CD8^+T细胞的比例以及肿瘤组织中CD3^+T细胞的浸润程度。结果:B16细胞接种同种皮肤移植组小鼠后瘤体生长缓慢,直至完全消失,而接种同系皮肤移植组小鼠和未移植组小鼠后瘤体生长迅速;SP2/0细胞接种同种皮肤移植组小鼠、同系皮肤移植组小鼠和未移植组小鼠后瘤体均生长迅速,3组之间差异无统计学意义。同种皮肤移植鼠脾细胞群中针对H-2K^b移植抗原的同种反应性CD8^+T细胞比例明显高于同系皮肤移植鼠。结论:同种皮肤移植引起的排斥反应只对拥有同种异基因的肿瘤细胞具有排斥作用,而对与受者基因同源的肿瘤细胞并无明显的交叉免疫反应。 Objective:To investigate the influence of skin allograft rejection on the anti-tumor effects in mice . Methods:BALB/c mice (H-2d genotype) were randomly assigned to 1 of 3 groups named as allograft group grafted with skin from C57BL/6 mice (H-2b genotype),syngeneic graft group grafted with skin from other BALB /c mice, and no graft group,respectively.Each mouse was administered subcutaneously with melanoma cells ( B16,H-2b genotype) derived from C57BL/6 mouse,or myeloma cells (SP2/0,H-2d genotype) derived from BALB/c mouse. The graft survival and tumor growth were then followed up .The percentages of spleen CD 3 +,CD8 +T cell and H-2Kb-alloreactive CD8 +T cell as well as the infiltration of CD 3 +T cell in tumor tissue were detected .Results:After B16 cells injection, tumor progressed very fast in both syngeneic graft group and no graft group , but a marked reduction in melanoma growth was found in allograft group followed by a complete tumor regression .After SP2/0 cells administration ,rapid tumor progression was found in allograft group ,syngeneic graft group and no graft group , with no differences on tumor growth curves .A higher frequency of H-2Kb-alloreactive CD8 +T cells was detected in the allograft mice compared with the syngeneic graft mice .Conclusion: Alloskin graft rejection may facilitate the rejection of allogeneic tumor cells ,but cannot cross-react with syngeneic tumor cells .
出处 《东南大学学报(医学版)》 CAS 北大核心 2016年第2期165-170,共6页 Journal of Southeast University(Medical Science Edition)
基金 国家自然科学基金面上项目(81172823 81372448)
关键词 同种皮肤移植 免疫排斥 肿瘤免疫治疗 allogeneic skin transplantation immune rejection tumor immunotherapy
  • 相关文献

参考文献7

  • 1YOLCUOGLU B, ONAL M A, SIPAHI O, et al. The effect of skin transplantation on tumor growth in mice [ J ]. Am J Surg, 1999,178:329-330.
  • 2段学章,许海苗,陈婧,王慧芬,胡瑾华.荷肝癌小鼠皮肤移植后肿瘤生长和相关免疫指标的比较研究[J].肝脏,2009,14(1):43-44. 被引量:1
  • 3GARROD K R, CAHALAN M D. Murine skin transplantation [ J/OL]. J Vis Exp,2008 ,Jan 16. doi : 10. 3791/634.
  • 4SHEN C,HE Y,CHENG K,et al. Killer artificial antigen-pres- enting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation [ J ]. Immunol Lett, 2011,138 : 144-155.
  • 5李妙晨,王伟,李晓娥,房坤,吴优,顾宁,沈传来.杀伤性人工抗原提呈细胞治疗小鼠皮肤移植排斥及其对治疗鼠整体免疫功能的影响[J].东南大学学报(医学版),2015,34(4):496-501. 被引量:2
  • 6YOSHIDA R,YONEDA Y, KURIYAMA M, et al. IFN-γ-and cell- to- cell contact- dependent cytotoxicity of allograft- induced macrophages against syngeneic tumor cells and cell Lines:an application of allografting to cancer treatment [ J ]. J Immunol, 1999,163 : 148-154.
  • 7MUIR G, RAJBABU K, CALLWEN C, et al. Preliminary evi- dence that the allogeneic response might trigger antitumour im munity in patients with advanced prostate cancer[ J]. BJU In-ternational, 2006,98 : 989 - 995.

二级参考文献19

  • 1李捍卫,王慧芬,王福生,金波,段学章.慢性乙型肝炎患者抗病毒治疗前后外周血树突状细胞和淋巴细胞亚群的变化及意义[J].中华实验和临床病毒学杂志,2006,20(1):43-46. 被引量:11
  • 2董伟民,陈宝安,丁家华,孙雪梅,邓晓静,张琰,毕延智,赵刚,高冲,孙耘玉,王骏,程坚.移植前选择性去除同种异体反应供者淋巴细胞预防移植物抗宿主病的实验研究[J].现代医学,2006,34(2):77-80. 被引量:3
  • 3褚莉莉,窦骏,赵枫姝,唐权,张爱凤,王永仿,顾宁.mIL-21基因转染的Sp2/0瘤苗细胞的抗肿瘤机制探讨[J].细胞与分子免疫学杂志,2007,23(6):507-510. 被引量:5
  • 4Zhu AX. Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma. Cancer, 2008, 15, 112:250-259.
  • 5Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol, 2005, 40:225-235.
  • 6Muir G, Rajbabu K, Callen C, et al. Preliminary evidence that the allogeneie response might trigger antitumour immunity in patients with advanced prostate cancer. BJU Int,2006, 98:989-995.
  • 7LAU H T, YU M, FONTANA A, et al. Prevention of islet al- lograft rejection with engineered myoblasts expressing FasL in mice [ J ]. Science, 1996,273 (5271): 109-112.
  • 8WHARENBY K A,STRALEY E E,KIM H,et al. Transduction of donor hematopoietic stem-progenitor cells with Fas ligand en- hanced short-term engraftment in a murine model of allogeneic bone marrow transplantation [ J ]. Blood ,2002,100(9) :3147-3154.
  • 9STRAUSS G, OSEN W, KNAPE I, et al. Membrane- bound CD95 ligand expressed on human antigen-presenting cells pre- vents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity[ J ]. Cell Death Differ, 2007,14(3) :480-488.
  • 10MIN W P, GORCZYNSKI R, HUANG X Y, et al. Dendritic ceils genetically engineered to express Fas ligand induce do- nor- specific hyporesponsiveness and prolong allograft survival [ J]. J Immunol,2000,164( 1 ) : 161-167.

共引文献1

同被引文献9

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部